Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M
Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from…
Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from…